NCT05666921 Alexithymia and Attachment Style in Patients With Somatic Symptoms
| NCT ID | NCT05666921 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meyer Children's Hospital IRCCS |
| Condition | Somatic Symptom Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-06-15 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-06-15 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate whether emotional awareness, attachment style and the ability to abstract and symbolize (IQ) influence the appearance of somatic symptoms. Hypothesis: the investigators expect the presence of somatic symptoms linked to the lower ability of emotional awareness, to lower ability to abstract and symbolize and to an insecure attachment style.
Eligibility Criteria
Inclusion Criteria: * Clinical condition characterized by somatic symptoms such as recurrent abdominal pain, recurrent vomiting, dyspepsia, psychogenic cough, and chronic functional pain (headache, migraine, musculoskeletal pain) for which an organic cause has been excluded and whose symptom has had a strong impact on the quality of life (presence of the symptom for six months, school absenteeism, social isolation, immobility, psychological distress, difficulty in participating in sports and extracurricular activities, etc.), as per Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria. * Age between 11 and 17 years * Italian speaking * Patients' and parents' consent Exclusion Criteria: * Cognitive and/or developmental impairment * Difficulty in understanding the Italian language * Presence of organic disease diagnosis * Lack of informed consent * Patient who does not meet DSM-5 criteria for somatic symptom disorder Caregiver exclusion criteria: * Cognitive deficits * Difficulty in understanding the Italian language * Lack of informed consent Control group population inclusion criteria: * Age between 11 and 17 years * Adequate knowledge of the Italian language * Consent to participate
Contact & Investigator
Rosanna Martin, MSc
PRINCIPAL INVESTIGATOR
Meyer Children's Hospital IRCCS
Frequently Asked Questions
Who can join the NCT05666921 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Somatic Symptom Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05666921 currently recruiting?
Yes, NCT05666921 is actively recruiting participants. Contact the research team at rosanna.martin@meyer.it for enrollment information.
Where is the NCT05666921 trial being conducted?
This trial is being conducted at Florence, Italy, Genova, Italy.
Who is sponsoring the NCT05666921 clinical trial?
NCT05666921 is sponsored by Meyer Children's Hospital IRCCS. The principal investigator is Rosanna Martin, MSc at Meyer Children's Hospital IRCCS. The trial plans to enroll 300 participants.